Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | FL118 |
Synonyms | |
Therapy Description |
FL118 is a DDX5 degrader, which reduces expression of downstream targets and potentially induces tumor cell apoptosis and inhibits tumor growth (PMID: 35604033). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
FL118 | FL 118|FL-118 | FL118 is a DDX5 degrader, which reduces expression of downstream targets and potentially induces tumor cell apoptosis and inhibits tumor growth (PMID: 35604033). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT06206876 | Phase I | FL118 | FL118 for Treating Patients With Advanced Pancreatic Ductal Adenocarcinoma | Not yet recruiting | USA | 0 |